Sub-optimized processes lead to undesirable business situations. Rejected batches, rework and deviations contribute to excessive waste. In the pharmaceutical industry, processes that are incapable of meeting product specification limits lead to potentially disastrous field alerts, recalls and FDA compliance actions. PC&C directly addresses these problems. This approach has tackled and scored excellent results in areas such as: · Low potency · Excessive water content · Excessive "picking and sticking" · Low dissolution rate · Low hardness · Excessive tablet defects To read how we boosted manufacturing capacity 40% in one major pharmaceutical firm, click here.